Menu Back toDay2-Session-4-A-Accelerating-Access-to-Health-Products

Accelerating Access to Innovative Products – Improving Responses to Pandemic Diseases


Day2: Session 4-A: Accelerating Access to Health Products

Session Chair(s)

Shun  Jin, MBA

Shun Jin, MBA

  • Head, Regulatory Affairs, APMA
  • Sandoz Asia Pacific Pharmaceutical Pte., Ltd., Singapore

Speaker(s)

Yoshikazu  Hayashi

D2:S4-A: 1.2: Overview of Early Access Regulatory Pathways for Innovation

Yoshikazu Hayashi

  • Associate Center Director (for New Drug Review)
  • Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Chen  Wan-yu

D2:S4-A: 1.3: Overview of Early Access Regulatory Pathways for Innovation

Chen Wan-yu

  • TFDA, Taiwan
Anuradha  Poonepalli

D2:S4-A: 1.4: Perspective of Dengue Vaccine Registration Process

Anuradha Poonepalli

  • Senior Regulatory Specialist, Health Products Regulation Grou
  • Singapore HSA, Singapore

Contact us